The Accuracy of Four Frequently Used Frailty Instruments for the Prediction of Adverse Health Outcomes Among Older Adults at Two Dutch Emergency Departments: Findings of the AmsterGEM Study - 23/09/21
, Marijke C. Trappenburg, MD, PhD a, Marieke M. ter Wee, PhD b, Emiel O. Hoogendijk, PhD b, Henrica C. de Vet, MD, PhD b, Yvo M. Smulders, MD, PhD c, Prabath W. Nanayakkara, MD, PhD d, Majon Muller, MD, PhD a, Mike J. Peters, MD, PhD a, cAbstract |
Study objective |
Older adults presenting to the emergency department (ED) are at high risk of adverse health outcomes. This study aimed to evaluate the accuracy of 4 frequently used screening instruments for the prediction of adverse health outcomes among older adults in the ED.
Methods |
This was a prospective cohort study in patients ≥70 years of age presenting to the ED in 2 hospitals in the Netherlands. Screening instruments included the acutely presenting older patient screening program (APOP) (providing 2 risk scores—functional decline [APOP1] and mortality [APOP2]), the International Resident Assessment Instrument Emergendy Department screener (InterRAI ED), the Identification of Seniors At Risk-Hospitalized Patients (ISAR-HP), and the safety management system (VMS). The primary outcome measure was a composite outcome encompassing functional decline, institutionalization, and mortality at 3 months after ED presentation. Other follow-up time points were 1 and 6 months. Analyses were performed to assess prognostic accuracy.
Results |
In total, 889 patients were included. After 3 months, 267 (31%) patients experienced at least 1 adverse outcome. The positive likelihood ratio ranged from 1.67 (VMS) to 3.33 (APOP1), and the negative likelihood ratio ranged from 0.41 (ISAR-HP) to 0.88 (APOP2). Sensitivity ranged from 17% (APOP2) to 74% (ISAR-HP), and specificity ranged from 63% (ISAR-HP) to 94% (APOP2). The area under the curve ranged from 0.62 (APOP2) to 0.72 (APOP1 and ISAR-HP). Calibration was reasonable for APOP1 and VMS. The prognostic accuracy was comparable across all outcomes and at all follow-up time points.
Conclusion |
The frailty screening instruments assessed in this study showed poor to moderate prognostic accuracy, which brings into question their usability in the prediction of adverse health outcomes among older adults who present to the ED.
Le texte complet de cet article est disponible en PDF.Plan
| Please see page 539 for the Editor’s Capsule Summary of this article. |
|
| Supervising editor: Steven M. Green, MD. Specific detailed information about possible conflict of interest for individual editors is available at editors. |
|
| All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. |
|
| Author contributions: CSD conceived and designed the analysis, collected the data, contributed to the data and analysis tools, performed the analysis, and wrote the paper. MCT conceived and designed the analysis, collected the data, contributed to the data and analysis tools, and wrote the paper. MMW conceived and designed the analysis, contributed to data and analysis tools, and wrote the paper. EOH conceived and designed the analysis, contributed to data and analysis tools, and wrote the paper. YMS conceived and designed the analysis, contributed to data and analysis tools, and wrote the paper. PWN conceived and designed the analysis, contributed to data and analysis tools, and wrote the paper. MM conceived and designed the analysis, contributed to data and analysis tools, and wrote the paper. MJP conceived and designed the analysis, collected the data, contributed to the data and analysis tools, and wrote the paper. |
|
| Readers: click on the link to go directly to a survey in which you can provide VSCZBDB to Annals on this particular article. |
|
| A podcast for this article is available at www.annemergmed.com. |
Vol 78 - N° 4
P. 538-548 - octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
